Legal & General Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $698M | Sell |
2,363,927
-117,396
| -5% | -$34.9M | 0.16% | 110 |
|
|
2025
Q4 | $678M | Buy |
2,481,323
+44,252
| +2% | +$12M | 0.15% | 116 |
|
|
2025
Q3 | $658M | Buy |
2,437,071
+124,820
| +5% | +$34M | 0.15% | 119 |
|
|
2025
Q2 | $637M | Buy |
2,312,251
+225,449
| +11% | +$61.3M | 0.16% | 120 |
|
|
2025
Q1 | $554M | Buy |
2,086,802
+45,353
| +2% | +$11.2M | 0.15% | 128 |
|
|
2024
Q4 | $474M | Sell |
2,041,449
-90,426
| -4% | -$20.8M | 0.13% | 152 |
|
|
2024
Q3 | $470M | Sell |
2,131,875
-49,475
| -2% | -$10.2M | 0.12% | 160 |
|
|
2024
Q2 | $429M | Buy |
2,181,350
+50,495
| +2% | +$10.4M | 0.12% | 156 |
|
|
2024
Q1 | $459M | Sell |
2,130,855
-4,071
| -0.2% | -$855K | 0.13% | 150 |
|
|
2023
Q4 | $450M | Sell |
2,134,926
-20,891
| -1% | -$4.46M | 0.14% | 142 |
|
|
2023
Q3 | $432M | Sell |
2,155,817
-92,004
| -4% | -$18.3M | 0.15% | 135 |
|
|
2023
Q2 | $416M | Buy |
2,247,821
+32,846
| +1% | +$6.07M | 0.14% | 151 |
|
|
2023
Q1 | $424M | Buy |
2,214,975
+32,532
| +1% | +$5.88M | 0.15% | 141 |
|
|
2022
Q4 | $367M | Sell |
2,182,443
-187,869
| -8% | -$32.6M | 0.14% | 161 |
|
|
2022
Q3 | $420M | Sell |
2,370,312
-117,332
| -5% | -$23.2M | 0.16% | 128 |
|
|
2022
Q2 | $509M | Buy |
2,487,644
+159,962
| +7% | +$33.9M | 0.18% | 111 |
|
|
2022
Q1 | $554M | Buy |
2,327,682
+144,726
| +7% | +$34M | 0.17% | 119 |
|
|
2021
Q4 | $499M | Sell |
2,182,956
-116,183
| -5% | -$25.6M | 0.15% | 132 |
|
|
2021
Q3 | $445M | Buy |
2,299,139
+87,913
| +4% | +$17.8M | 0.14% | 147 |
|
|
2021
Q2 | $470M | Sell |
2,211,226
-56,571
| -2% | -$11.9M | 0.16% | 133 |
|
|
2021
Q1 | $463M | Sell |
2,267,797
-12,304
| -0.5% | -$2.42M | 0.17% | 120 |
|
|
2020
Q4 | $415M | Buy |
2,280,101
+28,411
| +1% | +$4.83M | 0.16% | 130 |
|
|
2020
Q3 | $377M | Sell |
2,251,690
-39,583
| -2% | -$6.67M | 0.17% | 130 |
|
|
2020
Q2 | $372M | Buy |
2,291,273
+105,420
| +5% | +$18.9M | 0.18% | 120 |
|
|
2020
Q1 | $378M | Buy |
2,185,853
+54,775
| +3% | +$10.9M | 0.22% | 94 |
|
|
2019
Q4 | $428M | Buy |
2,131,078
+29,666
| +1% | +$6.09M | 0.2% | 106 |
|
|
2019
Q3 | $444M | Sell |
2,101,412
-16,629
| -0.8% | -$3.47M | 0.23% | 88 |
|
|
2019
Q2 | $411M | Sell |
2,118,041
-29,538
| -1% | -$5.45M | 0.22% | 96 |
|
|
2019
Q1 | $353M | Buy |
2,147,579
+331,439
| +18% | +$58.6M | 0.2% | 107 |
|
|
2018
Q4 | $342M | Buy |
1,816,140
+203,486
| +13% | +$37.6M | 0.26% | 79 |
|
|
2018
Q3 | $275M | Buy |
1,612,654
+34,772
| +2% | +$5.85M | 0.2% | 116 |
|
|
2018
Q2 | $259M | Sell |
1,577,882
-88,694
| -5% | -$14.5M | 0.2% | 119 |
|
|
2018
Q1 | $269M | Sell |
1,666,576
-227,930
| -12% | -$36.3M | 0.21% | 109 |
|
|
2017
Q4 | $277M | Buy |
1,894,506
+193,726
| +11% | +$27.6M | 0.2% | 117 |
|
|
2017
Q3 | $231M | Buy |
1,700,780
+60,352
| +4% | +$7.62M | 0.17% | 137 |
|
|
2017
Q2 | $205M | Buy |
1,640,428
+91,333
| +6% | +$10.9M | 0.17% | 145 |
|
|
2017
Q1 | $184M | Buy |
1,549,095
+54,353
| +4% | +$6.54M | 0.16% | 154 |
|
|
2016
Q4 | $172M | Buy |
1,494,742
+19,608
| +1% | +$2.18M | 0.16% | 150 |
|
|
2016
Q3 | $154M | Buy |
1,475,134
+24,999
| +2% | +$2.61M | 0.16% | 157 |
|
|
2016
Q2 | $141M | Buy |
1,450,135
+58,653
| +4% | +$5.54M | 0.15% | 163 |
|
|
2016
Q1 | $134M | Buy |
1,391,482
+27,322
| +2% | +$2.49M | 0.15% | 161 |
|
|
2015
Q4 | $124M | Buy |
1,364,160
+13,214
| +1% | +$1.24M | 0.14% | 166 |
|
|
2015
Q3 | $125M | Buy |
1,350,946
+55,152
| +4% | +$5.24M | 0.15% | 160 |
|
|
2015
Q2 | $121M | Buy |
+1,295,794
| New | +$121M | 0.14% | 174 |
|
Other funds holding CME
VCM
VPM
Legal & General Group's CME Position: Q1 2026 in Review
Legal & General Group reduced its CME Group (CME) stake by 4.7% in Q1 2026, selling an estimated $34.9M and leaving 2,363,927 shares worth $698M. The position accounts for 0.16% of the portfolio, ranked #110.
Legal & General Group first reported a position in CME in Q2 2015 and has held it in 44 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Legal & General Group held 2,363,927 shares of CME Group worth $698M as of Q1 2026.
- Legal & General Group sold 117,396 CME Group shares in Q1 2026, an estimated $34.9M.
- CME Group made up 0.16% of Legal & General Group's portfolio in Q1 2026, its #110 holding.
- Legal & General Group first reported a position in CME Group in Q2 2015 and has held it in 44 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.